Sintchenko Vitali, Iredell Jonathan R, Gilbert Gwendolyn L, Coiera Enrico
Centre for Health Informatics, University of New South Wales, UNSW, Sydney 2052.
J Am Med Inform Assoc. 2005 Jul-Aug;12(4):398-402. doi: 10.1197/jamia.M1798. Epub 2005 Mar 31.
This study assessed the effect of a handheld computer-based decision support system (DSS) on antibiotic use and patient outcomes in a critical care unit.
A DSS containing four types of evidence (patient microbiology reports, local antibiotic guidelines, unit-specific antibiotic susceptibility data for common bacterial pathogens, and a clinical pulmonary infection score calculator) was developed and implemented on a handheld computer for use in the intensive care unit at a tertiary referral hospital. System impact was assessed in a prospective "before/after" cohort trial lasting 12 months. Outcome measures were defined daily doses (DDDs) of antibiotics per 1,000 patient-days, patient length of stay, and mortality.
The number of admissions, APACHE (Acute Physiology, Age, and Chronic Health Evaluation) II and SAPS (Simplified Acute Physiology Score) II for patients in preintervention, and intervention (DSS use) periods were statistically comparable. The mean patient length of stay and the use of antibiotics in the unit during six months of the DSS use decreased from 7.15 to 6.22 bed-days (p = 0.02) and from 1,767 DDD to 1,458 DDD per 1,000 patient-days (p = 0.04), respectively, with no change in mortality. The DSS was accessed 674 times during 168 days of the trial. Microbiology reports and antibiotic guidelines were the two most commonly used (53% and 22.5%, respectively) types of evidence. The greatest reduction was observed in the use of beta-lactamase-resistant penicillins and vancomycin.
Handheld computer-based decision support contributed to a significant reduction in patient length of stay and antibiotic prescribing in a critical care unit.
本研究评估了基于手持计算机的决策支持系统(DSS)对重症监护病房抗生素使用及患者预后的影响。
开发了一个包含四种类型证据(患者微生物学报告、当地抗生素指南、常见细菌病原体的科室特定抗生素敏感性数据以及临床肺部感染评分计算器)的DSS,并在一台手持计算机上实施,供一家三级转诊医院的重症监护病房使用。在一项为期12个月的前瞻性“干预前/干预后”队列试验中评估系统影响。结局指标为每1000患者日的抗生素限定日剂量(DDD)、患者住院时间和死亡率。
干预前和干预(使用DSS)期间患者的入院人数、急性生理学与慢性健康状况评分系统(APACHE)II和简化急性生理学评分(SAPS)II在统计学上具有可比性。在使用DSS的六个月期间,单位内患者的平均住院时间和抗生素使用量分别从7.15个床日降至6.22个床日(p = 0.02),以及从每1000患者日1767 DDD降至1458 DDD(p = 0.04),死亡率无变化。在试验的168天内,DSS被访问了674次。微生物学报告和抗生素指南是最常使用的两种证据类型(分别为53%和22.5%)。观察到β-内酰胺酶耐药青霉素和万古霉素的使用减少最为明显。
基于手持计算机的决策支持有助于显著缩短重症监护病房患者的住院时间并减少抗生素处方。